Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sequenom, Inc.
With
PRA Health Sciences
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Subject is female
Subject is pregnant
Subject is 18 years of age or older
Subject provides a signed and dated informed consent
Subject agrees to provide a 30-50mL blood sample
Subject is at increased risk for Down syndrome or other aneuploidies (greater than or equal to 35 years of age at time of delivery, elevated risk by maternal serum markers including Triple, Quad and integrated test, fetal birth defects or markers identified by ultrasound or family history of aneuploidy).
Subject plans to undergo an amniocentesis and/or CVS procedure
Subject agrees that the FISH, karyotype, and/or QF-PCR results obtained via the invasive procedure will be provided
You may not be if
None
Clareo Health | Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
